Data as of Apr 17
| +0.13 / +0.73%|
The 6 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 24.50, with a high estimate of 30.00 and a low estimate of 21.00. The median estimate represents a +37.02% increase from the last price of 17.88.
The current consensus among 7 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.